Author Guidelines and Publishing Standards

1. About JourniVision

JourniVision is an independent international publisher that shares peer-reviewed research across many fields, with a focus on science, technology, and the social sciences. We are committed to academic integrity, transparency, and making research accessible. We believe knowledge should cross borders and disciplines, and that all researchers, no matter where they are from, should have the opportunity to publish work that meets high international standards.

To submit a manuscript to JourniVision, authors are required to follow the policies and procedures outlined on this page, which describe the steps for manuscript preparation, submission, and publication.

2. Scope and Publication Principles

JourniVision publishes original research articles, review papers, systematic reviews, perspectives, brief communications, editorials, case reports, and invited commentaries. Each journal within the JourniVision portfolio has its own editorial focus and aims, but all share a commitment to:

• Scientific rigor and originality: manuscripts must present authentic findings or analyses based on verifiable data.
• Ethical conduct: research must adhere to recognized international and institutional ethical standards.
• Transparency: authors must fully disclose conflicts of interest, funding sources, and data availability.
• Reproducibility: methods and datasets must be described with sufficient detail to enable verification.
• Inclusivity and accessibility: research should be communicated clearly and openly to the global academic community.

By submitting a manuscript to JourniVision, authors agree to abide by these publication principles and affirm that their work has not been published elsewhere or submitted simultaneously to another journal.

3. Authorship and Ethical Responsibilities

Authorship should reflect a genuine scholarly contribution. Each author must have made a significant intellectual input in at least one area, such as conceptualization, methodology, analysis, interpretation, drafting, or critical revision of the manuscript.

People who provided only administrative, technical, or editorial support should be acknowledged, but not listed as authors.

JourniVision follows the authorship guidelines set by the International Committee of Medical Journal Editors (ICMJE). All authors need to approve the final version of the manuscript and agree to submit it. Any authorship disputes should be settled by the researchers before submission.

Research involving human participants, animals, or biological specimens must include an explicit statement of ethical approval from a recognized institutional or national ethics committee. The ethical approval statement should specify the name of the committee, the approval reference number, and the date of approval, if applicable. Human studies must include confirmation of informed consent from all participants, and, where appropriate, consent from parents or legal guardians for minors or those unable to provide consent themselves. Authors should describe the procedures for obtaining consent and any steps taken to ensure participant confidentiality and data privacy. Animal experiments must comply with the relevant national and institutional guidelines on animal welfare, and authors should confirm that all efforts were made to minimize suffering and the number of animals used. If ethical approval or consent was not required, a clear justification should be provided.

All authors must declare any financial or non-financial interests that could influence, or seem to influence, how their research findings are interpreted. This includes things like employment, consultancies, stock ownership, honoraria, paid expert testimony, or patent applications. Being fully transparent is essential to keep the research process trustworthy. If there are no conflicts of interest, authors should clearly state that there are none to declare.

JourniVision upholds the standards defined by the Committee on Publication Ethics (COPE). Plagiarism, data fabrication, falsification, image manipulation, duplicate submission, or redundant publication are considered serious ethical violations and will result in rejection or retraction of the manuscript.

All submissions are checked with standard similarity detection tools, such as iThenticate or similar software. Usually, if a manuscript has unattributed similarity above about 15 to 20 percent (not counting references, methods, and standard phrases), editors will review it more closely. Overlap is always considered in context; even a lower percentage may not be acceptable if it includes a lot of copied or misused material. If there are serious concerns, the manuscript may be rejected. For published work, corrections or retractions may be issued according to COPE recommendations.

4. Manuscript Categories

Full-length research papers should report novel findings supported by appropriate data and analysis. The recommended word count is between 4,000 and 8,000 words, excluding references and supplementary materials.

• Title and author information
• Abstract (structured, 250 words maximum)
• Keywords (6–8 specific terms)
• Introduction
• Materials and Methods
• Results
• Discussion
• Conclusion
• Data Availability Statement
• Acknowledgments
• Conflicts of Interest
• References

Review articles bring together and critically evaluate published literature on a specific topic. They can be either narrative or systematic.

• Narrative reviews: up to 12,000 words
• Systematic reviews: up to 15,000 words and must comply with the PRISMA 2020 statement.

Each systematic review must include a “Methods” section describing the search strategy, inclusion/exclusion criteria, and quality assessment. For systematic reviews and meta-analyses, authors should follow the PRISMA 2020 guidelines. A PRISMA flow diagram illustrating the study selection process must be included either in the main text or as a supplementary figure. In addition, authors should add a brief “Standards of Reporting” subsection before the References, clearly stating that the PRISMA checklist has been completed and that all relevant items have been addressed. Where required by the journal, the completed PRISMA checklist should be submitted as a supplementary file.

These are concise reports of significant findings that merit rapid dissemination. Brief communications should not exceed 2,000 words and usually contain no more than four figures or tables.

Case studies describe unique clinical, scientific, or educational cases. Authors must adhere to the CARE Guidelines and submit the completed checklist with the manuscript. Patient consent is mandatory and must be explicitly stated.

Perspective papers share authors’ analytical viewpoints on new research areas, while Commentaries discuss recently published articles or current issues in science and policy. Both types should be no longer than 3,000 words.

Editorials are usually invited by the Editor-in-Chief and may discuss trends, policies, or reflections on topics relevant to the journal. Editorials are typically between 1,000 and 1,500 words.

5. Preparing Your Manuscript

The title page must include:

• Manuscript title (concise and descriptive, 10–15 words)
• Full names and affiliations of all authors
• ORCID iDs for each author
• Contact details for the corresponding author
• Funding and conflict-of-interest statements

To ensure accurate attribution and discoverability, the corresponding author must have an ORCID iD at the time of submission. It is also strongly recommended for all co-authors. Authors who do not have an ORCID ID can register for one free at https://orcid.org

Write a single-paragraph abstract of no more than 250 words. Summarize the research objectives, methods, main results, and conclusions. Do not include references, figures, or abbreviations in the abstract.

• Manuscripts should be prepared in Microsoft Word (.docx) or LaTeX (with all source files).
• Use double-line spacing, 12-point font, and continuous line numbers.
• Number pages consecutively.
• Avoid manual page breaks or forced spacing.

Use clear section headings and subheadings, numbered consecutively (e.g., 1, 1.1, 1.1.1). Do not number the abstract or acknowledgments.

Place figures and tables close to where they are first mentioned in the text and provide clear captions. For the initial submission, low-resolution images are acceptable. After acceptance, authors must give high-resolution files (300 dpi or higher) in TIFF, EPS, or PDF formats.

Figures should not exceed 10 MB each, and multi-panel figures must be combined into a single composite file. As a general guide for layout, figures intended for a single-column format should be prepared at a width of approximately 85 mm, while figures spanning two columns should be prepared at a width of about 180 mm. Authors should check that all labels, axes, and legends remain readable at these final sizes.

Tables must be editable and not submitted as images. Captions appear above tables, while explanatory notes or legends appear below. Avoid vertical rules and shading.

Authors are encouraged to submit a graphical abstract, a concise visual summary of the article’s key message, at a minimum resolution of 1200 × 480 pixels. Up to five bullet-point highlights (maximum 85 characters each) may be included to improve visibility.

Follow SI units and use internationally recognized nomenclature standards, such as IUPAC for chemical names and HGNC for gene symbols. Variables in equations should be italicized, and mathematical expressions should be created with an equation editor.

To promote transparency, completeness, and reproducibility, JourniVision requires authors to follow established international reporting guidelines appropriate to their study design. These standards help ensure high-quality reporting and facilitate robust peer review, replication, and ethical accountability. Authors should consult the relevant checklist before preparing their manuscript and submit the completed checklist as supplementary material where required by the guidelines.

Below are the recommended reporting frameworks:

• CONSORT – for randomized controlled trials.
• TREND – for non-randomized evaluations of behavioral and public health interventions.
• PRISMA (2020) – for systematic reviews and meta-analyses.
• CARE – for case reports and case studies.
• STROBE – for observational studies (cohort, case–control, cross-sectional).
• STREGA – for studies of genetic association.
• STARD – for diagnostic accuracy studies.
• TRIPOD – for studies developing or validating prediction models.
• COREQ – for qualitative research involving interviews or focus groups.
• ARRIVE – for preclinical research and studies involving animal experiments.
• CHEERS – for economic evaluations of health interventions.
• MOOSE – for meta-analyses of observational studies.

Authors should ensure that their manuscript includes all required elements as outlined in the applicable guideline. Reviewers and editors may request revisions if essential items are missing or unclear. By following these reporting standards, authors help strengthen the clarity, rigor, and trustworthiness of the published work.

6. Data, Figures, and Supplementary Materials

Authors are expected to follow responsible data management practices that ensure transparency, reproducibility, and long-term accessibility of all research outputs. All manuscripts must include a clear Data Availability Statement specifying where underlying data, code, and materials can be accessed, along with any limitations due to ethical, legal, or privacy restrictions. Wherever possible, authors should deposit datasets, scripts, and related documentation in recognized open repositories such as Zenodo, OSF, Figshare, or discipline-specific databases. Files should be well-organized, accompanied by metadata or README documentation, and provided in non-proprietary formats to support reuse by the wider community. When data cannot be shared openly, authors should provide a detailed justification and, where feasible, outline controlled access conditions.

Figures, tables, and supplementary materials should be prepared with clarity, accuracy, and accessibility in mind. All figures must be submitted in high-resolution formats and designed to remain legible when printed or viewed on various devices. Multi-panel figures should follow a consistent style, label structure, and visual hierarchy. Tables must be editable, clearly formatted, and accompanied by concise captions and explanatory footnotes where needed. Supplementary files are encouraged for extensive datasets, extended methodological details, additional analyses, or multimedia content that adds value beyond the main manuscript. Each supplementary item must be referenced appropriately within the text, and authors should ensure that all supportive materials meet the same ethical and technical standards as the primary manuscript.

Every manuscript must include a Data Availability Statement specifying where and how the data supporting the study’s findings can be accessed. When possible, datasets should be deposited in open repositories and identified by persistent identifiers (e.g., DOI or accession number).

Authors are strongly encouraged to deposit data, code, and related materials in reputable public repositories, such as OSF, Zenodo, Figshare, institutional repositories, or discipline-specific databases. If legal, ethical, or privacy issues prevent full open sharing, authors should clearly explain any restrictions and, if possible, state the conditions for data access.

Supplementary materials may include datasets, code, additional figures, audio-visual files, and extended methods. They should be clearly referenced in the main text and uploaded as separate files, ideally combined in a single ZIP archive.

Acceptable file types: Word, Excel, CSV, PDF, TIFF, PNG, JPEG, MP3, and MP4.

Images must not be enhanced, obscured, moved, or removed in ways that could misrepresent results. Adjusting brightness or contrast is allowed only if done uniformly and clearly stated.

All figures must have clear labels, good color contrast, and captions that are detailed enough for screen readers or people with low vision.

7. References and Citations

Accurate and consistent referencing is essential to maintaining the integrity of the scholarly record. Authors are responsible for ensuring that all cited works are correctly formatted, complete, and accessible. References must correspond exactly to in-text citations and should be prepared using reference management software when possible (e.g., EndNote, Zotero, Mendeley) to avoid formatting inconsistencies. All sources cited in the manuscript, including datasets, software, preprints, protocols, and supplementary materials, must be listed in the reference section. Unpublished observations or personal communications should be cited sparingly and only with explicit permission from the individuals involved.

JourniVision accepts Vancouver and ACS citation-sequence formats. Authors must select one style and apply it consistently throughout the manuscript, including references in the main text, figures, tables, and supplementary materials. Each journal within the JourniVision portfolio may specify a preferred citation style; authors should consult the individual journal’s “Instructions for Authors” page to confirm requirements. Manuscripts with inconsistent formatting may be returned to authors during initial screening.

In the Vancouver system, citations appear as numerals in square brackets (e.g., [1]) in the order they are first mentioned in the text. The final reference list must follow this exact numerical order. When a work has six or fewer authors, list all authors’ names; for seven or more authors, list the first six followed by et al. Journal names should be abbreviated according to standard indexing databases, such as PubMed.

Wherever possible, authors should include Digital Object Identifiers (DOIs) or stable URLs to ensure persistent access.

In the ACS citation-sequence style, references are indicated by superscript numerals (e.g.,¹,²,³) placed sequentially throughout the text. The reference list must follow this numbering strictly.

Authors should follow the conventions outlined in the ACS Guide to Scholarly Communication, including consistent use of italics, punctuation, and journal abbreviations. DOIs should be included when available, and references must be presented in a clear, uniform format.

JourniVision recognizes the growing importance of open science, data transparency, and the early dissemination of research findings. As such, preprints may be cited in the reference list, provided they are clearly identified as non-peer-reviewed content. Citations must include the preprint server name, year, title, authors, version (if applicable), and DOI or stable URL.

JourniVision permits authors to post and maintain preprints of their manuscripts on reputable servers (e.g., arXiv, bioRxiv, medRxiv, SSRN, or discipline-specific platforms) before submission and during peer review, under the following conditions:

• The preprint platform must be identified as hosting non-peer-reviewed work.
• The preprint DOI or URL must be disclosed at the time of submission.
• After acceptance, authors should update the preprint entry to reference the final published version, including its DOI and complete citation information.

In addition to preprints, datasets, software, protocols, and code repositories should be cited formally in the reference list using persistent identifiers (DOIs, accession numbers, or version numbers). This ensures credit, reproducibility, and long-term traceability.

8. Submission and Peer Review

All manuscripts must be submitted through the JourniVision online submission system. Submissions by email are not accepted. The corresponding author must make sure all co-authors have approved the submission.

Include a concise cover letter summarizing:

• The manuscript’s significance and novelty
• Confirmation that the work is original and not under consideration elsewhere
• Ethical compliance, conflict of interest, and funding disclosures
• Contact details of the corresponding author

JourniVision employs a Double blind peer review system unless otherwise stated. At least two independent reviewers evaluate each manuscript. Reviewers are selected based on expertise, impartiality, and the absence of conflicts of interest.

Authors may suggest reviewers, but the final selection rests with the editorial team.

After peer review, the editor may recommend acceptance, minor or major revision, or rejection. Authors should address all reviewer comments clearly and in an organized way during revision.

Authors may request withdrawal of their manuscript at different stages of the process:

• Before peer review begins: the corresponding author may request withdrawal via the submission system, stating the reason. Once confirmed, the manuscript will be removed from active consideration.
• During or after peer review: withdrawal requests should include a clear justification and confirmation that all co-authors agree. JourniVision reserves the right to continue investigating any ethical concerns, even if withdrawal is requested.
• After acceptance or publication: requests will be managed under the journal’s correction, expression of concern, or retraction procedures, as appropriate and in line with COPE guidance.

9. Post-Acceptance and Production

After acceptance, manuscripts go through copyediting and typesetting. Authors will receive proofs to check and must return them within the given timeframe. Proofs should be reviewed only for typos and factual errors. Significant changes are not allowed at this stage. Authors usually have 3 to 5 working days to review and return proofs. If there is no response within this period, the publisher may move forward with publication to avoid delays, as long as no serious issues have been raised. Usually, only one round of proof corrections is allowed. Extra rounds may be considered only in exceptional cases.

Once finalized, articles are published online in both HTML and PDF formats. Authors will receive a digital object identifier (DOI) and a final citation format upon publication.

10. Open Access, Copyright, and Licensing

All JourniVision publications are open access, so articles are free and available to readers worldwide right away. Authors keep their copyright but give JourniVision a non-exclusive license to publish.

Articles are distributed under the Creative Commons Attribution (CC BY 4.0) license. This allows others to share and adapt the work for any purpose, provided appropriate credit is given to the authors and source.

Authors are responsible for obtaining permission for any copyrighted materials (figures, tables, or text extracts) used within their manuscripts. The source and license type must be clearly indicated in the caption or acknowledgment.

If the work was prepared as part of employment with a government or intergovernmental organization that does not allow copyright retention, please notify the editorial office during submission so that the appropriate copyright statement can be used.

JourniVision is committed to being transparent about any publication fees.

• Any Article Processing Charges (APCs) applied to accepted articles will be clearly stated on the individual journal’s webpage, along with the currency and conditions.
• JourniVision does not charge submission fees; fees, where applicable, are payable only after acceptance.
• To support authors with limited funding, some journals may offer partial or complete waivers or discounts, especially for authors from low- and middle-income countries or without institutional support. Eligibility criteria and application procedures, where available, are detailed on each journal’s site.

Authors should check the relevant journal’s homepage for the latest information on APCs and waivers.

11. Integrity, Misconduct, and AI-Generated Content

JourniVision screens all submissions using standard plagiarism detection tools. Manuscripts with substantial overlap or duplication will be rejected or retracted. Self-plagiarism, redundant publication, or division of one study into multiple papers without a valid justification (“salami slicing”) is not acceptable. Similarity reports are assessed in context, and authors may be asked to provide explanations or revisions where overlap is identified.

Digital image alteration that changes or misrepresents the original data is considered misconduct. Quantitative data must not be selectively reported to exaggerate results.

The use of artificial intelligence tools (e.g., for writing, editing, translation, or figure generation) must be disclosed in the manuscript. AI tools cannot be listed as authors. Authors bear full responsibility for verifying the accuracy, originality, and ethical compliance of all AI-assisted content.

Authors may appeal editorial decisions by submitting a reasoned letter to the Editor-in-Chief. Appeals are reviewed by an independent editorial board member who was not involved in the initial decision.

12. Language, Editing, and Presentation

Manuscripts must be written in clear, grammatical English. Either British or American spelling may be used, but consistency is required throughout the document.

Authors whose first language is not English are encouraged to have their manuscripts checked by professional editing services before submission. Language quality will not affect the editorial decision if the science is sound, but clear writing helps with peer review and readership.

Ensure that headings, subheadings, tables, and figures follow a uniform format. Include continuous numbering for figures and tables. Verify all in-text citations correspond accurately to the reference list.

Before submitting, please confirm that:

• All authors meet authorship criteria and approve submission.
• The manuscript is complete with abstract, keywords, and references.
• Ethical and conflict-of-interest statements are included.
• All figures and tables are cited sequentially and carry descriptive captions.
• The file is in an editable format and does not exceed the platform’s size limits.

13. After Publication

After publication, articles are indexed, given DOIs, and made available as open access. Authors are encouraged to share links to their work instead of sending out separate PDF copies. This helps preserve citation tracking and usage metrics.

Corrections, retractions, or expressions of concern will follow COPE’s best practice guidelines. Authors discovering significant errors post-publication must notify the editorial office promptly to arrange corrections.

Information about indexing and abstracting (e.g., DOAJ, Scopus, Web of Science, PubMed, and other databases where applicable) is provided on each journal’s homepage. New journals may initially be under evaluation by indexing services; updates on indexing status will be posted as they become available.

JourniVision may also display article-level metrics such as citation counts, downloads, and alternative metrics (where supported) to help authors understand the reach and use of their work.

• Corrections (Errata/Corrigenda): issued when an error is identified that does not invalidate the main conclusions but requires formal clarification.
• Retractions: issued when there is clear evidence that findings are unreliable (due to misconduct or honest error), that the research is unethical, or that there has been a serious breach of publication ethics.
• Expressions of Concern: may be published while an investigation is ongoing or when evidence is inconclusive but potentially serious.

All such notices remain permanently linked to the original article to maintain transparency of the scholarly record.

If an editor believes a manuscript is scientifically sound but better suited to another title within the JourniVision portfolio, authors may be offered the option to transfer.

Transfers will occur only with the corresponding author’s consent, and peer-review reports may be forwarded to the receiving journal to streamline the process, while maintaining reviewer confidentiality. The receiving journal will make its own independent editorial decision.

14. Contact and Support

For queries regarding manuscript preparation, submission procedures, or policies, authors should contact the JourniVision Editorial Office through the info@journivision.com. Administrative or technical support is available to assist authors throughout the submission and review process.

JourniVision’s editorial team is committed to making the publication process transparent, respectful, and efficient. We value the trust authors place in us to share their work responsibly and to maintain the academic standards that define scholarly communication worldwide.